Literature DB >> 9700509

The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.

K Tanaka1, M Kasahara.   

Abstract

Production of antigenic peptides that serve as MHC class I ligands is essential for initiation of cell-mediated immunity. Accumulating evidence indicates that the proteasome, a large multisubunit protein deg radative machine in eukaryotes, functions as a processing enzyme responsible for the generation of MHC class I ligands. This processing system is elaborately regulated by various immunomodulatory cytokines. In particular, interferon-gamma induces the formation of immunoproteasomes and a recently identified proteasomal regulatory factor. PA28, which in concert contribute to efficient production of MHC class I ligands. Many of the MHC-encoded genes including LMP appear to have emerged by an ancient chromosomal duplication, suggesting that modifications and renewal of pre-existing non-immune genes were instrumental in the emergence of adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700509     DOI: 10.1111/j.1600-065x.1998.tb01195.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  80 in total

1.  Follicle cell proteasome activity and acid extract from the egg vitelline coat prompt the onset of self-sterility in Ciona intestinalis oocytes.

Authors:  R Marino; R De Santis; P Giuliano; M R Pinto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes.

Authors:  H Kawahara; M Kasahara; A Nishiyama; K Ohsumi; T Goto; T Kishimoto; Y Saeki; H Yokosawa; N Shimbara; S Murata; T Chiba; K Suzuki; K Tanaka
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

4.  The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.

Authors:  Mizuho Kajikawa; Pai-Chi Li; Eiji Goto; Naoyuki Miyashita; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mika Ikegaya; Yuji Sugita; Satoshi Ishido
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 5.  Degradation of damaged proteins: the main function of the 20S proteasome.

Authors:  Andrew M Pickering; Kelvin J A Davies
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Thymic stromal cell subsets for T cell development.

Authors:  Takeshi Nitta; Harumi Suzuki
Journal:  Cell Mol Life Sci       Date:  2016-01-29       Impact factor: 9.261

7.  Transspecies dimorphic allelic lineages of the proteasome subunit beta-type 8 gene (PSMB8) in the teleost genus Oryzias.

Authors:  Fumi Miura; Kentaro Tsukamoto; Ratnesh Bhai Mehta; Kiyoshi Naruse; Wichian Magtoon; Masaru Nonaka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-23       Impact factor: 11.205

8.  Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA.

Authors:  Larry J Dishaw; Manuel L Herrera; Charles H Bigger
Journal:  Immunogenetics       Date:  2006-03-22       Impact factor: 2.846

9.  Structure and function of a novel type of ATP-dependent Clp protease.

Authors:  Fredrik I Andersson; Anders Tryggvesson; Michal Sharon; Alexander V Diemand; Mirjam Classen; Christoph Best; Ronny Schmidt; Jenny Schelin; Tara M Stanne; Bernd Bukau; Carol V Robinson; Susanne Witt; Axel Mogk; Adrian K Clarke
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

10.  Neuronal induction of the immunoproteasome in Huntington's disease.

Authors:  Miguel Díaz-Hernández; Félix Hernández; Ester Martín-Aparicio; Pilar Gómez-Ramos; María A Morán; José G Castaño; Isidro Ferrer; Jesús Avila; José J Lucas
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.